Riskpilot← Back to searchSign inGet full accessOcular Medical Services AB
ABActiveOrg 5569384976Önologgatan 1Medical specialists activities · NACE 8622Est. 20131 employees
Revenue 2025
SEK 2,7M
-10% vs 2024
EBITDA margin
79.7%
+35% vs 2024
Equity ratio
40.2%
Financial strength
Net profit 2025
SEK 755K
-15% vs 2024
| Revenue | SEK 2,7M | -10% |
| EBITDA | SEK 2,1M | +35% |
| Net profit | SEK 755K | -15% |
| Total assets | SEK 21,1M | +0% |
| Equity | SEK 8,5M | +7% |
| Employees | 1 | — |
Legal name
Ocular Medical Services AB
Org number
5569384976
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 augusti 2013
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall arbeta med vård tjänster inom öppen och slutenvård samt omsorg och därmed förenlig verksamhet. Vidare skall bolaget bedriva management- och juridiska tjänster samt handel och förvaltning av värdepapper och fastigheter inom Sverige och EU-länder och därmed förenlig verksamhet.
Address
Önologgatan 1
Email
nikolaos.kabolis@ocularmedical.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 835 | 1 684 | 2 434 | 2 960 | 2 671 |
| Staff expenses | — | −824 | −856 | −913 | −749 |
| EBITDA | −171 | 494 | 1 124 | 1 572 | 2 129 |
| Depreciation & amort. | −113 | −148 | −148 | −428 | −479 |
| EBIT | −284 | 345 | 976 | 1 144 | 1 650 |
| Net financials | −29 | −180 | −259 | −567 | −696 |
| Profit before tax | −313 | 3 166 | 717 | 1 127 | 954 |
| Tax | −0 | −597 | −160 | −239 | −199 |
| Net profit | −313 | 2 568 | 557 | 889 | 755 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 9 567 | 12 048 | 16 024 | 21 177 | 21 130 |
| Equity | 5 504 | 7 753 | 7 809 | 7 933 | 8 495 |
| Long-term debt | 3 600 | 3 420 | 7 040 | 12 347 | 12 142 |
| Short-term debt | 463 | 876 | 1 175 | 897 | 493 |
| Total debt | 4 063 | 4 296 | 8 215 | 13 244 | 12 636 |
EBITDA margin
79.7%
This company
15.8%
Market median
+404% vs market
20212025
Equity ratio
40.2%
This company
38.2%
Market median
+5% vs market
20212025
Return on equity
8.9%
This company
18.4%
Market median
-52% vs market
20212025
Net profit margin
28.3%
This company
8.1%
Market median
+249% vs market
20212025
Asset turnover
0.13×
This company
1.12×
Market median
-88% vs market
20212025
Debt / equity
1.49×
This company
0.62×
Market median
-140% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2020 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Ocular Medical Services AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Panagiotis Kampolis | Deputy Board Member | 0 companies |
| Nikolaos Merkoudis | Deputy Board Member | 0 companies |
| Nikolaos Kabolis | Board of Directors | 0 companies |